Dermata Therapeutics (DRMA) Stock Analysis
NASDAQHealthcareBiotechnology
Track DRMA in your portfolio for free · Portfolio tracker
What Dermata Therapeutics does
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Key metrics
ETFs linked to DRMA
Broad-market and Healthcare sector ETFs an investor holding Dermata Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how DRMA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze DRMA in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Dermata Therapeutics?
- Dermata Therapeutics trades under the ticker DRMA on NASDAQ.
- Which exchange is DRMA listed on?
- DRMA is listed on NASDAQ.
- What sector does Dermata Therapeutics operate in?
- Dermata Therapeutics is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze DRMA in a portfolio?
- PortView shows DRMA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.